The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy

BACKGROUND: As a parameter integrating platelet (P), neutrophil (N), and lymphocyte (L) levels, the systemic immune-inflammation index (SII) has been used as a prognostic marker for patient survival in various types of solid malignant tumors. However, there is no in-depth study in non-small-cell lun...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanan, Chen, Zeyang, Jin, Feng, Guo, Dong, Chen, Qingqing, Liu, Zhengcao, Ji, Shengjun, Gao, Guanqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570891/
https://www.ncbi.nlm.nih.gov/pubmed/34744510
http://dx.doi.org/10.1155/2021/2910892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570891/
https://www.ncbi.nlm.nih.gov/pubmed/34744510
http://dx.doi.org/10.1155/2021/2910892

Ejemplares similares